A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT05165849 · WITHDRAWN
Trial details
- NCT number
- NCT05165849
- Sponsor
- Zhejiang Genfleet Therapeutics Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2022-05-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.